Completed NA INTERVENTIONAL 1-arm NCT00986349

Study of EndoBarrier Liner for Treatment of Type 2 Diabetes Study

A Phase II Single-Center, Prospective, Open Label Efficacy Study, of the GI EndoBarrier™ Liner for the Treatment of Type 2 Diabetes

Sponsor: Morphic Medical Inc.

Conditions Type 2 Diabetes

Interventions EndoBarrier Liner

Updated 7 times since 2017 Last updated: Jan 3, 2017 Started: Jun 30, 2010 Primary completion: Nov 30, 2011 Completion: Nov 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Type 2 Diabetes and is currently completed. Morphic Medical Inc. leads this study, which shows 7 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Aug 2024 — Sep 2024 [monthly]

Completed NA
Jul 2024 — Aug 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jun 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Morphic Medical Inc.

Data source: Morphic Medical Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• São Paulo, Brazil